← Open Payments lookup

MARTINA ZILIC: Open Payments

NPI 1730871161 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$424 in 13 payments from 7 companies in 2025. Trend: 2023 $179 · 2024 $358 · 2025 $424

Food & beverage: $424
CompanyPaymentsAmount
Janssen Biotech, Inc.6$171
BTG International Inc.1$99
Takeda Pharmaceuticals U.S.A., Inc.2$53
Adaptive Biotechnologies Corporation1$32
Karyopharm Therapeutics Inc.1$27
Celgene Corporation1$22
Legend Biotech USA Inc.1$21

Products named: VORAXAZE, TECVAYLI, CARVYKTI, NINLARO, clonoSEQ, TALVEY, XPOVIO, ABECMA.

Industry payments across WA — which companies pay providers there.